Tachyplesin activates the classic complement pathway to kill tumor cells.
about
Studies on anticancer activities of antimicrobial peptidesScalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional ChemotherapeuticsIdentifying anticancer peptides by using improved hybrid compositionsAcyl-substituted dermaseptin S4 derivatives with improved bactericidal properties, including on oral microfloraComplement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells.Gene interaction enrichment and network analysis to identify dysregulated pathways and their interactions in complex diseasesResistance to degradation and cellular distribution are important features for the antitumor activity of gomesin.Prognostic stromal gene signatures in breast cancer.Oncolytic activities of host defense peptides.Retrocyclins and their activity against HIV-1.Targeted delivery of a proapoptotic peptide to tumors in vivo.From antimicrobial to anticancer peptides. A review.Quantitative Proteomic Profiling of Tachyplesin I Targets in U251 Gliomaspheres.The antibacterial peptide ABP-CM4: the current state of its production and applications.Antimicrobial peptides: versatile biological properties.Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides.Structure and Biological Functions of β-Hairpin Antimicrobial Peptides.Comparative in vitro study on cytotoxicity of recombinant β-hairpin peptides.Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers.Toxicological analysis of low-nicotine and nicotine-free cigarettes.Design of NK-2-derived peptides with improved activity against equine sarcoid cells.High-level Expression of Cecropin X in Escherichia coli.Tumor cell membrane-targeting cationic antimicrobial peptides: novel insights into mechanisms of action and therapeutic prospects.Comparison of Cytotoxic Activity in Leukemic Lineages Reveals Important Features of β-Hairpin Antimicrobial Peptides.Effect of N- and C-Terminal Modifications on Cytotoxic Properties of Antimicrobial Peptide Tachyplesin I.
P2860
Q24650885-44AE8CB4-F532-469F-B692-6460F7A19087Q28548620-57858E80-1323-4161-BF1F-9929438C6CB5Q28828941-6142C510-2F5B-4140-99EF-532597E07E0BQ33260522-8B424BB6-27F8-45FE-9B44-9429C6BCA8EDQ33457187-C563ECB5-B38D-4AD1-9C8E-502C16D1F6DEQ34302997-946594AF-FAE0-416B-B657-7D9B37B1864BQ35060387-1C307068-1679-4A6C-BEB5-6FEF2BD4FA10Q35180291-DA9BF102-EAB1-424D-A270-D4298B6368BBQ35600198-6341B060-D170-4D19-8DBE-5D696BB50929Q35879590-A3B79605-B79A-425F-A224-AC0382F8EA27Q35884337-A9C1D921-7C6F-4132-BCC4-DD6F3948AC2EQ37207728-68128810-4B52-4704-A340-587599F12920Q37628648-10989235-8E7B-401E-9E3C-DD057C5EA4F4Q37909101-4BC721E9-479D-4BE1-ABB4-36783096CCCCQ38128298-A0192D10-DD59-4A5F-929C-46AD1246B3F2Q38160482-B002FE17-F0FE-4E47-9C94-15D52D98406AQ38450909-6359F049-F821-4351-AF55-89DE4AF1C793Q38694731-1AD335D7-B35A-4F3C-8975-2398DC09EB44Q41390340-224B1633-F740-4217-89DE-CB2BF6D9887EQ41872268-6B95EE87-46DA-4BDD-B4A4-4B050D54B739Q42280878-AB79786B-9069-4E03-860E-45117A3F23C6Q46047892-A361CF66-CA90-4FDE-9686-3E3D36657A71Q46326633-D4284006-D99F-45BC-9F4C-0AF7AE322B97Q51253671-7F733509-43C8-4B20-AEC4-A46E1103FFEFQ53743069-A2F3BA60-61D0-462A-AD88-949FEC9319C9
P2860
Tachyplesin activates the classic complement pathway to kill tumor cells.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Tachyplesin activates the classic complement pathway to kill tumor cells.
@ast
Tachyplesin activates the classic complement pathway to kill tumor cells.
@en
type
label
Tachyplesin activates the classic complement pathway to kill tumor cells.
@ast
Tachyplesin activates the classic complement pathway to kill tumor cells.
@en
prefLabel
Tachyplesin activates the classic complement pathway to kill tumor cells.
@ast
Tachyplesin activates the classic complement pathway to kill tumor cells.
@en
P2093
P1433
P1476
Tachyplesin activates the classic complement pathway to kill tumor cells.
@en
P2093
Charles B Underhill
Jinguo Chen
Karen Creswell
Luping Wang
Lurong Zhang
Shanmin Yang
Shuigen Hong
Xue-Ming Xu
Yixin Chen
P304
P356
10.1158/0008-5472.CAN-04-2253
P407
P577
2005-06-01T00:00:00Z